Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
The level of viral infection of antigen-presenting cells is critical for the development of TMEV-induced demyelinating disease.
Protective effect of a germline, IL-17-neutralizing antibody in murine models of autoimmune inflammatory disease.
Walking Distance as a Predictor of Falls in People With Multiple Sclerosis.
Intractable cough as characteristic symptom of neuromyelitis optica and neuromyelitis optica spectrum disorder.
Implication of matrix metalloproteinases in regulating neuronal disorder.
A Case of Neuromyelitis Optica Masquerading as Miller Fisher Syndrome.
Long-term epidemiology of multiple sclerosis in the Northern Seville District.
Natalizumab SC Similar to IV Every 4 Weeks for MS
Optic neuritis following aseptic meningitis associated with modified measles: a case report.
Vitamin d: shining a light on clinical and sex specific effects in multiple sclerosis?
Dimethyl fumarate for treatment of multiple sclerosis: mechanism of action, effectiveness, and side effects.
Month of birth in multiple sclerosis with and without longitudinally extensive spinal cord lesions: A study of a Japanese national survey.
Secondary progressive NMO, or concomitant NMO and a primary neurodegenerative disorder?
Latent virus infection upregulates CD40 expression facilitating enhanced autoimmunity in a model of multiple sclerosis.
Sulforaphane induces Nrf2 target genes and attenuates inflammatory gene expression in microglia from brain of young adult and aged mice.
Translational Biomarkers of Neurotoxicity: A Health and Environmental Sciences Institute Perspective on the Way Forward.
The management and outcomes of fingolimod first dose cardiac monitoring in UK patients with relapsing-remitting multiple sclerosis.
Remodeling myelination: implications for mechanisms of neural plasticity.
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.
"Central vessel sign" on 3T FLAIR* MRI for the differentiation of multiple sclerosis from migraine.
Expression Profile of Long Non-Coding RNAs in Serum of Patients with Multiple Sclerosis.
Changes in Synaptic Transmission and Long-term Potentiation Induction as a Possible Mechanism for Learning Disability in an Animal Model of Multiple Sclerosis.
Comparative study of the efficacy of limaprost and pregabalin as single agents and in combination for the treatment of lumbar spinal stenosis: a prospective, double blind, randomized controlled non-inferiority trial.
Case centered analysis of Optic Neuritis following vaccines.
Dietary phytochemicals and neuro-inflammaging: from mechanistic insights to translational challenges.
Pages
« first
‹ previous
…
602
603
604
605
606
607
608
609
610
…
next ›
last »